Kasaei Abdollah, Mobini-Dehkordi Mohsen, Mahjoubi Foruzandeh, Saffar Behnaz
Genetics Department, Faculty of Science, Shahrekord University, Shahrekord, Iran.
Research institute of Biotechnology, Shahrekord University, Shahrekord, Iran.
Curr Microbiol. 2017 Jun;74(6):702-709. doi: 10.1007/s00284-017-1231-0. Epub 2017 Mar 23.
Taxol or paclitaxel, an approved drug by the Food and Drug Administration, is being used for the treatment of human cancers. This study aimed to isolate and determine different species of native endophytic fungi from Iranian Taxus baccata (yew) plants located in the northern forests of Iran. To do so, a novel molecular screening approach was performed for 50 isolated endophytic fungi through amplification of exon No. 1 of taxadine synthase as a key gene in taxol production pathway. We used effective colony-polymerase chain reaction technique for rapid screening of potent taxol-producing fungi instead of genomic DNA extraction. Production of taxol was performed in batch culture by selected fungi individually and produced taxol was assayed quantitatively by high-performance liquid chromatography using standard taxanes. We found that only six fungi could produce taxol and baccatin III. Interestingly, after 7 days of incubation, the highest level of taxol was found to be 129 and that of baccatin 139.2 mg/kg dw for two native isolated Cladosporium sp. named F1 and F3. The fungal taxols could decrease cell viability in MTT assay same as commercial taxol. The fungal taxols semi-quantitatively showed antimitotic effects on MCF-7 cells as human breast cancer cell line. The expression of bcl-2 anti-apoptotic gene, in contrast to bax pro-apoptotic gene, significantly decreased after treatment by standard and fungal taxols. As fungal taxol was produced simpler than other methods and could significantly affect viability and specific genes expression profile, it is recommended that using of taxol-producing fungi from Iranian yew could be a safe and confident procedure to overcome challenges of using other methods.
紫杉醇,一种已获美国食品药品监督管理局批准的药物,正用于治疗人类癌症。本研究旨在从位于伊朗北部森林的伊朗红豆杉植物中分离并鉴定不同种类的本地内生真菌。为此,通过扩增紫杉二烯合酶第1外显子(紫杉醇生产途径中的关键基因),对50株分离出的内生真菌进行了一种新型分子筛选方法。我们采用有效的菌落聚合酶链反应技术快速筛选高效生产紫杉醇的真菌,而不是提取基因组DNA。选定的真菌分别在分批培养中生产紫杉醇,并使用标准紫杉烷通过高效液相色谱法定量测定所产生的紫杉醇。我们发现只有六种真菌能够产生紫杉醇和巴卡亭III。有趣的是,培养7天后,两种本地分离的枝孢菌属(命名为F1和F3)产生的紫杉醇最高水平为129mg/kg干重,巴卡亭为139.2mg/kg干重。真菌紫杉醇在MTT试验中与商业紫杉醇一样可降低细胞活力。真菌紫杉醇对人乳腺癌细胞系MCF-7细胞半定量显示出抗有丝分裂作用。与促凋亡基因bax相比,标准紫杉醇和真菌紫杉醇处理后,抗凋亡基因bcl-2的表达显著降低。由于真菌紫杉醇的生产比其他方法更简便,且能显著影响细胞活力和特定基因表达谱,因此建议利用伊朗红豆杉中产生紫杉醇的真菌可能是一种安全可靠的方法,以克服使用其他方法所面临的挑战。